FDA MedWatch Alert: Impella Heart Pump Sensor Malfunction Risk

The U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding a potential safety issue with certain Impella heart pump devices manufactured by Abiomed. The alert concerns the differential pressure sensor within the devices, which may malfunction. Specifically, the sensor values are reported to potentially drift, leading to inaccurate readings. The Impella devices are temporary ventricular support systems used during high-risk percutaneous coronary interventions or in patients with cardiogenic shock. A malfunctioning sensor could compromise the accuracy of hemodynamic monitoring and potentially impact the safe and effective operation of the pump, which is critical for patient circulatory support. The FDA is communicating this information while the agency and the manufacturer continue to evaluate the issue. This alert serves as an early notification to healthcare providers to be aware of the potential problem. The FDA advises providers to report any adverse events or quality problems involving these devices through the MedWatch Safety Information and Adverse Event Reporting program. Further instructions or recommendations from Abiomed or the FDA may follow as the investigation progresses.